In conclusion, in early stage endometrial cancers, a significant reduction in TRPM7 ion channel activity relative to endometrial hyperplasia may be a progression marker for endometrial hyperplasia independently of the atypia criteria. Here, TRPM7 is linked to endometrial cancer.